October 2019

Fred is the CEO and co-founder of Multiply Labs. Fred holds a PhD in Mechanical Engineering from the Massachusetts Institute of Technology (MIT) and has extensive experience in the design and control of autonomous robotic systems. Prior to his research at MIT, Dr. Parietti has worked on advanced robotics at the Carnegie Mellon University, the Polytechnic University of Milan (Italy) and ETH Zurich (Switzerland).

As the co-founder of Multiply Labs, Fred raised a $3.5M seed round from investors including Y Combinator, the leading startup accelerator in Silicon Valley. Fred recruited...Read more

Dr. McLoughlin began his career as a researcher in the electronics industry in the 1990’s. He currently has over 20 years experience in the pharmaceutical industry and has worked in the development and commercialization of device and combination products across a range of therapeutic areas, treatment modalities and routes of administration including inhalation and injection.

He has led the development of several commercially launched devices and combination products including needle safety devices, mechanical and electronic auto-injectors. He has had end-to-end responsibility from...Read more

Ahmed Zidan has over 16 years of experience in the industry, Academia and FDA as a formulation and manufacturing scientist across a broad range of roles in development, process, and manufacturing of complex dosage forms. Ahmed is currently a senior staff fellow at the Office of Testing and Research of Center of Drug Evaluation and Research of FDA. Ahmed is leading the formulation and manufacturing translational research on complex dosage forms such as transdermal and oral drug products at Office of Testing and Research of CDER. He has made also significant contribution in identifying the...Read more

Jose E. Tabora is a Senior Scientific Director in the Chemical Process Development department at Bristol Myers Squibb in New Brunswick, New Jersey. He received a B.S. in chemical engineering from Louisiana State University in 1990 and a M.S. and Ph.D. in chemical engineering from the University of Virginia under Profs. J. L. Hudson and R. J. Davis, respectively. 

Over the past 25 years, he has worked for Merck, Eli Lilly and BMS in drug substance development, primarily in chemical synthesis of small molecules intended for oral dosage. He has enthusiastically championed the use...Read more